Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Improving access and adherence for overactive bladder treatment

Official title: Improving Overactive Bladder Treatment Access and Adherence Through Personalized Behavioral Modifications and Mobile Technology-Based Interventions

Run by Stanford University · NCT06094543 · Data updated 2026-11-12

This study is testing a new tool to help women with overactive bladder get better access to treatment and stick with it, so they can feel better and improve their quality of life.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment30 (estimated)
SponsorStanford University
Academic / other
Locations1 site (Redwood City, California)
StatusRecruiting
StartedNovember 1, 2024
Main results expectedAugust 2027
Study endsDecember 2027
Registry record updatedJuly 21, 2026
Trial IDNCT06094543 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are females aged 18 years or older who have experienced OAB symptoms for at least three months and have not previously received behavioral treatment.

Probably not a fit

Patients with certain comorbid conditions, such as interstitial cystitis or neurological disorders, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to enhance the treatment access and adherence for individuals suffering from overactive bladder (OAB) and urinary incontinence (UI), conditions that affect millions of Americans. It will utilize a patient engagement tool designed to address barriers to treatment, such as cost and tolerability, and to improve overall quality of life. The study focuses on female patients aged 18 and older who have experienced OAB symptoms for at least three months and have not previously undergone behavioral treatment. By identifying and supporting vulnerable populations, the study seeks to increase therapy utilization and adherence among those most in need.

Why it matters

Potential benefit: If successful, this study could significantly improve treatment adherence and quality of life for patients with overactive bladder and urinary incontinence.

How similar studies have gone: Other studies have shown success in improving treatment adherence for chronic conditions through patient engagement strategies, indicating that this approach is promising.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female aged 18 years or older
* OAB symptoms for at least 3 months
* English/Spanish language skills and cognitive status sufficient to complete all study related materials
* Behavioral treatment naïve patients
* Previously treated OAB patients without supervised pelvic floor physical therapy or pharmacotherapy within 1 year

Exclusion Criteria:

* Post void residual urine \> 150ml
* Confirmed diagnosis of Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)
* Pregnant or breastfeeding patients
* Patients residing in a nursing home
* Comorbid neurological conditions, including spinal cord injury, progressive neurologic illnesses (e.g. Multiple Sclerosis, Parkinson's disease) or central nervous system disease (e.g. brain tumor, stroke)
* Stage 2 or greater pelvic organ prolapse
* Any history of urethral stricture
* Any history of pelvic irradiation
* Any history of bladder malignancy
* Current symptomatic urinary tract infection (UTI), unresolved by the time of enrollment
* Hematuria without a clinical evaluation
* History or current use of indwelling urinary foley catheterization, suprapubic tube or intermittent catheterization
* Patients with UI treated with onabotulinumtoxinA, sacral neuromodulation, or percutaneous tibial nerve stimulation (third line therapies)

Where it's running

  • Stanford Pelvic Health Center
    Redwood City, California, United States
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.